Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Pseudogenes are non-functional segments of DNA that resemble functional genes but have lost their protein-coding ability due to disruptive mutations such as frame shifts or premature stop codons. Chromosome 9 open reading frame 86 pseudogene (ENSG00000266522) is annotated as a pseudogene on human chromosome 9 and does not encode a functional protein. Pseudogenes are classified based on their origin: as processed, duplicated, or unitary pseudogenes. Most pseudogenes do not produce biologically active products, but rare cases may have partial activity—such as being transcribed into noncoding RNA—though there is no evidence for such activity for this specific locus. Pseudogenes generally do not have therapeutic, disease, or biomarker roles and are not considered direct drug targets[1][2][4]. This entry is not a receptor, enzyme, transporter, or any established therapeutic target. It is correctly annotated as a pseudogene, meaning it is not associated with the typical biological functions, molecular families, interacting drugs, or disease roles considered in target-based drug discovery[1][2][4].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Chromosome 9 open reading frame 86 pseudogene.